HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lauder Q1: Firm Discusses China Tariff Uncertainties, Imminent Clinique Customization Launch

This article was originally published in The Rose Sheet

Executive Summary

The firm is confident that prestige beauty demand in China will remain a constant, translating to double-digit growth over the long term, but it’s taking a prudent approach to guidance in light of possible tariff impacts, among other unknowns. Lauder’s first-quarter sales totaled $3.52bn, up 11% in organic terms.

Advertisement

Related Content

L’Oreal: 2018 Nine-Month Results Clearly Show ‘It’s Not The End Of The Big Brands’
Cosmetics Industry, Consumers Will Lose Under Latest Tariff Proposal In US-China Feud
Lauder Upbeat About Clinique, While Namesake Shows ‘Big Brands Can Grow Fast’

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS122489

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel